Lakefront Biotherapeutics NV (LKFT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $29.90, -0.10% vs the prior close of $29.93.
- Volume 250.89K shares, 0.8x its 50-day average.
- New SEC filings: 6-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
LKFT ends flat (-0.1%) to $29.90. Closed at $29.90, -0.10% vs the prior close of $29.93. Day range $29.36–$30.01, opened at $29.93.
LKFT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — LKFT ends flat (-0.1%) to $29.90
- Closed at $29.90, -0.10% vs the prior close of $29.93. Day range $29.36–$30.01, opened at $29.93.
- Volume was 250.89K shares, 0.8x its 50-day average of 299.23K.
- Price is +3.9% vs its 50-day average ($28.79) and -0.3% vs its 200-day average ($30.00).
- 52-week range $25.68–$36.24; today's close sits at 40% of that range, 17.5% below the 52-week high.
Oct 15, 2026 — LKFT rises 1.8% to $29.93
- Closed at $29.93, +1.80% vs the prior close of $29.40. Day range $29.71–$30.34, opened at $29.74.
- Volume was 227.20K shares, 0.8x its 50-day average of 301.08K.
- Price is +4.2% vs its 50-day average ($28.71) and -0.3% vs its 200-day average ($30.02).
- 52-week range $25.68–$36.24; today's close sits at 40% of that range, 17.4% below the 52-week high.
- SEC filings that day: 6-K.
Oct 14, 2026 — LKFT rises 1.2% to $29.40
- Closed at $29.40, +1.20% vs the prior close of $29.05. Day range $28.50–$29.45, opened at $28.68.
- Volume was 226.60K shares, 0.7x its 50-day average of 303.18K.
- Price is +2.7% vs its 50-day average ($28.63) and -2.1% vs its 200-day average ($30.03).
- 52-week range $25.68–$36.24; today's close sits at 35% of that range, 18.9% below the 52-week high.
Oct 13, 2026 — LKFT dips 1.8% to $29.05
- Closed at $29.05, -1.76% vs the prior close of $29.57. Day range $29.04–$29.62, opened at $29.42.
- Volume was 175.90K shares, 0.6x its 50-day average of 303.66K — lighter than usual.
- Price is +1.7% vs its 50-day average ($28.58) and -3.3% vs its 200-day average ($30.05).
- 52-week range $25.68–$36.24; today's close sits at 32% of that range, 19.8% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — LKFT dips 0.5% to $29.57
- Closed at $29.57, -0.54% vs the prior close of $29.73. Day range $29.46–$29.93, opened at $29.65.
- Volume was 220.20K shares, 0.7x its 50-day average of 302.81K.
- Price is +3.6% vs its 50-day average ($28.53) and -1.7% vs its 200-day average ($30.07).
- 52-week range $25.68–$36.24; today's close sits at 37% of that range, 18.4% below the 52-week high.
Oct 9, 2026 — LKFT rises 0.7% to $29.73
- Closed at $29.73, +0.75% vs the prior close of $29.51. Day range $29.33–$29.95, opened at $29.51.
- Volume was 212.50K shares, 0.7x its 50-day average of 302.12K.
- Price is +4.4% vs its 50-day average ($28.48) and -1.2% vs its 200-day average ($30.09).
- 52-week range $25.68–$36.24; today's close sits at 38% of that range, 18.0% below the 52-week high.
- SEC filings that day: 6-K.
Oct 8, 2026 — LKFT dips 1.6% to $29.51
- Closed at $29.51, -1.63% vs the prior close of $30.00. Day range $28.66–$30.13, opened at $29.83.
- Volume was 505.00K shares, 1.7x its 50-day average of 297.13K.
- Price is +3.8% vs its 50-day average ($28.44) and -2.0% vs its 200-day average ($30.10).
- 52-week range $25.68–$36.24; today's close sits at 36% of that range, 18.6% below the 52-week high.
Oct 7, 2026 — LKFT rises 2.3% to $30.00
- Closed at $30.00, +2.32% vs the prior close of $29.32. Day range $28.96–$30.05, opened at $29.09.
- Volume was 362.30K shares, 1.2x its 50-day average of 292.42K.
- Price is +5.6% vs its 50-day average ($28.40) and -0.4% vs its 200-day average ($30.11).
- 52-week range $25.68–$36.24; today's close sits at 41% of that range, 17.2% below the 52-week high.
Oct 6, 2026 — LKFT dips 0.6% to $29.32
- Closed at $29.32, -0.64% vs the prior close of $29.51. Day range $29.09–$29.90, opened at $29.75.
- Volume was 452.10K shares, 1.6x its 50-day average of 285.56K.
- Price is +3.4% vs its 50-day average ($28.37) and -2.7% vs its 200-day average ($30.12).
- 52-week range $25.68–$37.00; today's close sits at 32% of that range, 20.8% below the 52-week high.
- SEC filings that day: 6-K.
Oct 5, 2026 — LKFT rises 0.5% to $29.51
- Closed at $29.51, +0.48% vs the prior close of $29.37. Day range $29.24–$29.91, opened at $29.38.
- Volume was 439.70K shares, 1.6x its 50-day average of 280.11K.
- Price is +4.1% vs its 50-day average ($28.34) and -2.1% vs its 200-day average ($30.13).
- 52-week range $25.68–$37.78; today's close sits at 32% of that range, 21.9% below the 52-week high.
Oct 2, 2026 — LKFT rises 1.8% to $29.37
- Closed at $29.37, +1.77% vs the prior close of $28.86. Day range $28.88–$29.44, opened at $28.94.
- Volume was 270.20K shares, 1.0x its 50-day average of 277.53K.
- Price is +3.7% vs its 50-day average ($28.31) and -2.6% vs its 200-day average ($30.14).
- 52-week range $25.68–$37.78; today's close sits at 30% of that range, 22.3% below the 52-week high.
LKFT latest news & SEC filings
Every SEC filing by or about LKFT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 18, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 12, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade LKFT
- How much it moves: over the last 20 sessions the average daily move was 1.53% (largest 3.6%).
- Liquidity: about 312.97K shares (≈$9.36M) trade per day on average.
- 52-week position: $29.90 vs a range of $25.68–$36.24 (40% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 15, 2026; 6-K Oct 13, 2026; 6-K Oct 9, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
LKFT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 29.93 | 30.01 | 29.36 | 29.90 | 250.89K |
| Oct 15, 2026 | 29.74 | 30.34 | 29.71 | 29.93 | 227.20K |
| Oct 14, 2026 | 28.68 | 29.45 | 28.50 | 29.40 | 226.60K |
| Oct 13, 2026 | 29.42 | 29.62 | 29.04 | 29.05 | 175.90K |
| Oct 12, 2026 | 29.65 | 29.93 | 29.46 | 29.57 | 220.20K |
| Oct 9, 2026 | 29.51 | 29.95 | 29.33 | 29.73 | 212.50K |
| Oct 8, 2026 | 29.83 | 30.13 | 28.66 | 29.51 | 505.00K |
| Oct 7, 2026 | 29.09 | 30.05 | 28.96 | 30.00 | 362.30K |
| Oct 6, 2026 | 29.75 | 29.90 | 29.09 | 29.32 | 452.10K |
| Oct 5, 2026 | 29.38 | 29.91 | 29.24 | 29.51 | 439.70K |
| Oct 2, 2026 | 28.94 | 29.44 | 28.88 | 29.37 | 270.20K |
| Oct 1, 2026 | 29.31 | 29.82 | 28.71 | 28.86 | 341.50K |
| Sep 30, 2026 | 29.83 | 30.08 | 29.59 | 29.65 | 188.60K |
| Sep 29, 2026 | 29.70 | 29.93 | 29.48 | 29.52 | 198.90K |
| Sep 28, 2026 | 29.01 | 30.03 | 28.96 | 29.84 | 206.60K |
| Sep 25, 2026 | 30.15 | 30.19 | 29.30 | 29.38 | 250.70K |
| Sep 24, 2026 | 30.09 | 30.67 | 29.86 | 30.36 | 435.30K |
| Sep 23, 2026 | 31.13 | 32.41 | 30.66 | 30.72 | 635.30K |
| Sep 22, 2026 | 29.57 | 30.28 | 29.57 | 30.19 | 451.80K |
| Sep 21, 2026 | 28.67 | 29.73 | 28.60 | 29.59 | 208.10K |
About Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV (LKFT) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in 2800 MECHELEN. State of incorporation: Belgium. Fiscal year ends —. SEC CIK 1421876.
LKFT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
LKFT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
LKFT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LKFT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.